Clin2
NCT06474455Possibly a fitRecruiting

Study of SHR-9839 with other treatments for advanced solid tumors

Advanced Solid Tumors

Treatments studied

Part of Cancer clinical trials.

This trial tests a new drug called SHR-9839 combined with other cancer treatments for people with advanced solid tumors, including a certain type of lung cancer. The goal is to see if the combination is safe and effective against the cancer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
156 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have a type of cancer that has spread or cannot be removed by surgery (advanced solid tumor). If you have squamous non-small cell lung cancer, you may also qualify.
  • You are able to get out of bed and take care of yourself most of the day (ECOG 0 or 1).
  • You haven't had chemotherapy, radiation, or major surgery in the last 4 weeks.
  • Your cancer has not spread to the brain and caused active symptoms, or if it did, it has been treated and is stable.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06906731Not yet recruiting· Phase 1/Phase 2
SHR-9803 for advanced solid tumors

This trial tests an experimental drug called SHR-9803 for people with advanced solid tumors. It aims to see if the drug is safe and works against cancer.

Harbin, Heilongjiang
NCT06618651Recruiting· Phase 1
Study of SHR-3821 for advanced solid tumor cancers

This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.

Chengdu, Sichuan
NCT06907628Recruiting· Phase 1
Testing SHR-3792 for advanced solid tumors

This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.

Jinan, Shandong
NCT06703177Recruiting· Phase 1/Phase 2
Study of SHR-1826 combo for advanced solid tumors

This trial tests a new drug, SHR-1826, combined with other cancer treatments for people with advanced solid tumors that have not responded to prior therapy. The goal is to see if the combination is safe and effective.

Guangzhou, Guangdong
NCT06443489Recruiting· Phase 1
SHR-4849 for advanced solid tumors

This trial tests a new drug called SHR-4849 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and effective, and may offer a new option for those who have limited choices.

Jilin City, Changchun
NCT06605222Recruiting· Phase 1/Phase 2
Testing SHR-7787 for advanced solid tumors

This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.

Shanghai, Shanghai Municipality

Hear when a new Advanced Solid Tumors trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.